
California Technology Ventures
Description
California Technology Ventures, LLC (CTV) is a Pasadena, California-based venture capital firm with a strategic focus on early-stage technology and life science companies. Established to bridge the gap between innovative research and commercial viability, CTV primarily targets businesses poised for significant growth within these high-potential sectors. The firm's investment philosophy centers on identifying disruptive technologies and scientific breakthroughs that can address critical market needs.
CTV typically engages with companies in their Seed, Series A, and Series B funding rounds, indicating a preference for businesses that have moved beyond the conceptual stage but are still in the early phases of scaling. Their investment range is notably defined, with typical first cheques falling between $500,000 and $5,000,000. This range suggests a commitment to providing substantial initial capital to help portfolio companies achieve key developmental milestones, such as product development, market entry, or team expansion.
While specific details on their most recent activities are less publicly prominent, historical data indicates a focused portfolio. For instance, Crunchbase reports approximately 10 investments made by the firm, alongside around 3 reported exits. These figures suggest a selective investment approach, focusing on a manageable number of companies where they can potentially offer more hands-on support or leverage their network. Their historical presence in the Southern California innovation ecosystem underscores their role in fostering regional technological and scientific advancements.
Investor Profile
California Technology Ventures has backed more than 43 startups, with 0 new investments in the last 12 months alone. The firm has led 12 rounds, about 28% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, China.
- Strong thematic focus on Health Care, Medical Device, Biotechnology.
- Typical check size: $500K – $5M.
Stage Focus
- Series B (23%)
- Series A (19%)
- Series C (16%)
- Series D (12%)
- Series Unknown (12%)
- Series F (7%)
- Seed (5%)
- Secondary Market (2%)
- Debt Financing (2%)
- Series E (2%)
Country Focus
- United States (98%)
- China (2%)
Industry Focus
- Health Care
- Medical Device
- Biotechnology
- Medical
- Software
- Manufacturing
- Gaming
- Health Diagnostics
- Life Science
- Cloud Management
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.